ABOUT

Advocate | Connect | Inspire

Strategic Priorities

About_ImproveHealth_750pixels

Improve the health of people, animals and the environment

About_ExpandJobs_750pixels

Expand the number of high paying, advanced technology jobs

About_StudentAchievement_750pixels

Enhance student achievement in science education

About Georgia Bio

Georgia Bio (GaBio), founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry.  It is the state’s largest and most influential life sciences advocacy and business leadership organization which works to improve access to innovative technologies and grow Georgia’s life sciences economy. Members include companies, universities, research institutions, government groups and other industry associations involved in discovery and application of life sciences products and related services that improve the health and well-being of people throughout the world.

Summer 2023, Georgia Bio recommitted to its core mission of advocating for, connecting, educating and inspiring our member enterprises and stakeholders in much the same way our colleagues have known Georgia Bio since its inception in 1989. To achieve this, the organization transitioned from a 501c3 to an independent 501c6 organization, Georgia Biosciences Organization, Inc. You can read more about this on our blog here. Our new EIN# is 27-3855537.

The life science industry encompasses any initiative aimed at improving the quality and standard of life. Its many industry sectors include biotechnology, medical devices, biopharmaceuticals, health IT/digital health, research institutes, global health, bio-agriculture and bio-fuel. Georgia Bio is fully-funded through memberships, sponsorships, and event registration fees.

Mission

Georgia Bio's mission is to advance the growth of Georgia’s life sciences industry and foster strategic partnerships that can create a healthier world.

To accomplish this mission, GaBio conducts business and economic development activities; advocates on behalf of the industry on public policy matters; educates the public about the benefits of life sciences research and product development; and provides a network for the exchange of ideas, information and opportunities.

National Partnerships

advamed.logo
BIO-Rebrand_LogoColors_FNL
Phrma

AdvaMed | State Medical Technology Alliance (SMTA)

BIO | Council of Bioscience Associations (CSBA)

PhRMA, the Pharmaceutical Research and Manufacturers of America

The State Medical Technology Alliance (SMTA) is a consortium of state and regional trade associations representing their local medical technology companies. SMTA’s mission is to collectively support the medical technology industry on the local, state and national levels by fostering a collaborative environment through sharing of best practices, promoting the industry, and advocating for public policies that support innovation. Learn more here.

Georgia Bio is the state affiliate of the Washington, D.C.-based Biotechnology Innovation Organization (BIO), making Georgia Bio members part of statewide, national and international promotional and advocacy networks for the life sciences industry, the Council of State Bioscience Associations (CSBA). CSBA is a confederation of state-based, non-profit trade organizations each governed by its own board of directors. The Georgia Bio President is a past chair of this board. The common mission of the members of the CSBA is to promote public understanding, and to advocate for public policies that support the responsible development of the bioscience industry. This confederation provides Georgia Bio members with access to discount vendor programs through the BIO Business Solutions program. Learn more here.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone. Learn more here.

National Partnerships

advamed.logo

AdvaMed | State Medical Technology Alliance (SMTA)

The State Medical Technology Alliance (SMTA) is a consortium of state and regional trade associations representing their local medical technology companies. SMTA’s mission is to collectively support the medical technology industry on the local, state and national levels by fostering a collaborative environment through sharing of best practices, promoting the industry, and advocating for public policies that support innovation. Learn more here.

BIO Logo

BIO | Council of Bioscience Associations (CSBA)

Georgia Bio is the state affiliate of the Washington, D.C.-based Biotechnology Innovation Organization (BIO), making Georgia Bio members part of statewide, national and international promotional and advocacy networks for the life sciences industry, the Council of State Bioscience Associations (CSBA). CSBA is a confederation of state-based, non-profit trade organizations each governed by its own board of directors. The Georgia Bio President is a past chair of this board. The common mission of the members of the CSBA is to promote public understanding, and to advocate for public policies that support the responsible development of the bioscience industry. This confederation provides Georgia Bio members with access to discount vendor programs through the BIO Business Solutions program. Learn more here.

Phrma

PhRMA, the Pharmaceutical Research and Manufacturers of America

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone. Learn more here.